EDIELYN QUIJANO: Open Payments
NPI 1982974705 · BALDWIN PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 14 payments from 5 companies in 2025. Trend: 2023 $929 · 2024 $492 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $288 |
| Abbott Laboratories | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Amgen Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $17 |
Products named: Wegovy, Ozempic, FREESTYLE LIBRE 3, BREZTRI, EVENITY, AIRSUPRA, FARXIGA, Korlym.
Industry payments across CA — which companies pay providers there.
